CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 57,250 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01090362
NCT01090362N/ACompleted

Prospective, Multi Centre, International Registry of Male and Female Patients Newly Diagnosed With Atrial Fibrillation.

Thrombosis Research Institute·observational·Posted Mar 19, 2010·Updated Apr 28, 2021

In Brief

An observational study for Atrial Fibrillation. Completed, enrolled 57,250 participants across 35 sites in 35 countries.

Detailed Summary

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a non-interventional, observational study that characterized a global population of non-valvular atrial fibrillation patients. The registry was used to document global baseline characteristics, current treatment strategies and outcome measures. Characterisation of a number of AF sub-populations was also completed. GARFIELD-AF is an independent academic research initiative sponsored by the Thrombosis Research Institute (London, UK) and supported by an unrestricted research grant from Bayer AG (Berlin, Germany).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesArgentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Egypt, Finland, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey (Türkiye), Ukraine, United Arab Emirates, United Kingdom, United States

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 19, 2010
Enrollment StartDec 21, 2009
Primary CompletionJun 16, 2019
Study CompletionMay 18, 2020
TodayJul 2, 2026
Enrollment to primary: 9.5 yearsPosted 16.3 years ago